Other

Galenea Corp.

Laurence I Wu

Sharon Shacham

Xiang Y Yu

Oren Becker

Ashis K Saha

Srinivasa Rao Cheruku

Yael Marantz

Silvia Noiman

Dale S Dhanoa

Mercedes Lobera

Anurag Sharadendu

Hanoch Senderowitz

Merav Fichman

Pini Orbach

Rosa Melendez

A compound useful for treating leukemia or myelodysplastic syndrome, having the structure of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ris H or &#x2014;C(&#x2550;O)&#x2014;O&#x2014;R, and Ris H or &#x2014;C(&#x2550;O)&#x2014;O&#x2014;R, provided Rand Rare not both H; and Rand Rare each independently selected from the group consisting of alkyl, alkenyl, alkynyl, aryl, arylalkyl, cycloalkyl, cycloheteroalkyl, and heteroalkyl. In an exemplary compound of formula (I), Ris &#x2014;C(&#x2550;O)&#x2014;O&#x2014;CH&#x2014;CH, and Ris H.

Methods for treating cancers by prodrugs of clofarabine

A compound useful for treating lymphoma, having the structure of formula (I): 

Prodrugs of clofarabine

The invention relates to 5-HTreceptor antagonists. Novel arylamine compounds and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating obesity, and obesity-related disorders, e.g., cardiovascular disease, digestive disease, respiratory disease, cancer and type II diabetes; and psychological disorders such as schizophrenia, are disclosed.

Substituted arylamine compounds and methods of treatment

Growing community of inventors

Tainan, Taiwan

Laurence I Wu